Cymbalta (duloxetine) Dosage
Pronounced: (dull-OX-eh-teen)
Overdose
If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US National Poison Hotline at 1-800-222-1222. Canada residents can call a provincial poison control center.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to...
Read moreMore information on "Cymbalta (duloxetine) Dosage"
From Our Experts
Cymbalta Hits a Bump in Its Road to FDA Approval
It has long been thought that Cymbalta (generic name duloxetine) would be the second medication to receive FDA approval for the treatment... Read more »
Cymbalta
Generic name: Duloxetine Cymbalta is an antidepressant medication. It has been approved for use in treating symptoms of depression and... Read more »
Antidepressants: Cymbalta
You've probably seen the television commercials or magazine ads for Cymbalta, and you might be wondering what makes it different from other... Read more »
Cymbalta Approved for Fibromyalgia
Today Eli Lilly and Co. announced the FDA approval of Cymbalta (duloxetine HCI) for the management of fibromyalgia. Cymbalta is the first... Read more »
Cymbalta Study Shows Reduction in Chronic Low Back Pain
If Cymbalta (duloxetine) sounds familiar, it may be because it recently received FDA approval for the management of fibromyalgia. Now a... Read more »
From Our Sources
Clinical Trial: Cymbalta for Multiple Sclerosis Pain
This is a study to determine the safety and effectiveness of different doses of Cymbalta (duloxetine) compared to a placebo in reducing pain in... Read more »
FDA Approves Cymbalta for Chronic Joint, Muscle Pain
The antidepressant Cymbalta (duloxetine hydrochloride) has been approved by the U.S. Food and Drug Administration for the treatment of chronic... Read more »
Clinical trial: Cymbalta for MS-related pain
This is a study to evaluate the safety and effectiveness of Cymbalta compared to a placebo in treating pain in people who have multiple sclerosis... Read more »
Cymbalta's chronic pain application withdrawn--for now
Drugmaker Eli Lilly and Co. withdrew its application to the U.S. Food and Drug Administration for its antidepressant Cymbalta to be approved for use... Read more »
Cymbalta maintains chronic pain relief: study
Drugmaker Eli Lilly is reporting that its drug Cymbalta was effective at the long-term reduction of chronic low back pain in a new study. For the... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
